Shanghai Henlius Biotech (HKSE:02696) Change In Inventory : HK$25 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Henlius Biotech Change In Inventory?

Shanghai Henlius Biotech's change in inventory for the quarter that ended in Dec. 2024 was HK$65 Mil. It means Shanghai Henlius Biotech's inventory declined by HK$65 Mil from Jun. 2024 to Dec. 2024 .

Shanghai Henlius Biotech's change in inventory for the fiscal year that ended in Dec. 2024 was HK$25 Mil. It means Shanghai Henlius Biotech's inventory declined by HK$25 Mil from Dec. 2023 to Dec. 2024 .

Shanghai Henlius Biotech's Total Inventories for the quarter that ended in Dec. 2024 was HK$778 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shanghai Henlius Biotech's Days Inventory for the quarter that ended in Dec. 2024 was 176.61.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shanghai Henlius Biotech's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shanghai Henlius Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.25.

Shanghai Henlius Biotech Change In Inventory Historical Data

The historical data trend for Shanghai Henlius Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Henlius Biotech Change In Inventory Chart

Shanghai Henlius Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-63.69

-112.29

-380.40

-24.43

25.48

Shanghai Henlius Biotech Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial										-252.66	-53.19	28.76	-40.18	65.32

Shanghai Henlius Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$25 Mil.

Shanghai Henlius Biotech (HKSE:02696) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shanghai Henlius Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	810.4195	/	837.453	*	365 / 2
	=	176.61

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shanghai Henlius Biotech's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	837.453	/	810.4195
	=	1.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shanghai Henlius Biotech's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	810.4195	/	3179.89
	=	0.25

Shanghai Henlius Biotech Change In Inventory Related Terms

Thank you for viewing the detailed overview of Shanghai Henlius Biotech's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Henlius Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Henlius Biotech Inc (HKSE:02696) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

B8 Building, No. 188 Yizhou Road, 11th Floor, Xuhui District, Shanghai, CHN, 200233

Website

https://www.henlius.com

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China, Asia Pacific (excluding Mainland China), North America, South America, Oceania, and Europe. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Executives

Ubs Group Ag
Golden Valley Value Select Master Fund	2101 Beneficial owner
Vistra Trust (singapore) Pte. Limited	2301 Trustee
Lvc Sg Management Pte. Ltd.	2201 Interest of corporation controlled by you
Lvc Management Holdings Limited	2201 Interest of corporation controlled by you
Lin Lijun	2201 Interest of corporation controlled by you
Qatar Investment Authority	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun Industrial Co., Limited	2101 Beneficial owner
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Liu Scott Shi-kau	2201 Interest of corporation controlled by you

Shanghai Henlius Biotech Headlines

No Headlines